IP Library Granted Patent US 8,968,733
Granted Patent B2
US 8,968,733 · App. 12/708,776 · Granted Mar 3, 2015

Functionalized surgical adhesives

Inventor: Sebastien Ladet (Lyons, FR)
Assignee: Sofradim Production
A61L24/04A61L24/001
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,968,733
App. No.
12/708,776
Granted
Mar 3, 2015
Kind
B2
Abstract

A bioadherent composition includes a first mixture containing a plurality of reactive members of a specific binding pair, said reactive members being bound to a ligand capable of binding a receptor on biological tissue, and a second mixture containing a plurality of complementary reactive members of the specific binding pair, said complementary reactive members being bound to a ligand capable of binding a receptor on biological tissue, said reactive members capable of forming covalent bonds with said complementary reactive members via a reaction selected from Huisgen cycloaddition reactions, Diels-Alder reactions, and/or thiol-alkene reactions. A method for bonding biological tissue involves utilizing the bioadherent composition.

Claims (13)

1. A method for bonding biological tissue comprising: providing a first mixture containing a plurality of reactive members of a specific binding pair, the reactive members conjugated to a first ligand wherein the first ligand is capable of binding specifically to a first receptor on a first biological tissue surface; providing a second mixture containing a plurality of complementary reactive members of the specific binding pair, the complementary reactive members conjugated to a second ligand wherein the second ligand is capable of binding specifically to a second receptor on a second biological tissue surface; applying the first mixture to the first biological tissue surface to bind the first ligand to the first biological tissue surface and affix the reactive members to the first biological tissue surface; applying the second mixture to a second biological tissue surface to bind the second ligand to the second biological tissue surface and affix the complementary reactive members to the second biological tissue surface; wherein the members of the specific binding pair are alkynes and azides, and contacting the reactive members affixed to the first biological tissue surface with the complimentary reactive members affixed to the second biological tissue surface to form covalent bonds between the reactive members and the complementary reactive members, thus adhering the first biological tissue surface to the second biological tissue surface.

2. The method for bonding biological tissue according to claim 1 wherein the members of the specific binding pair bind to one another via a Huisgen cycloaddition reaction.

3. The method for bonding biological tissue according to claim 1 wherein the reactive member is an alkyne and the complementary reactive member is an azide.

4. The method for bonding biological tissue according to claim 1 wherein the reactive members is an azide and the complementary reactive member is an alkyne.

5. The method for bonding biological tissue according to claim 2 wherein the reaction is catalyzed by copper to activate the alkyne and the azide for [3+2] cycloaddition.

6. The method for bonding biological tissue according to claim 1 wherein the first ligand is selected from the group consisting of antibody, Fab, F(ab') 2 , Fv, single chain antibody (SCA) and single complementary-determining region (CDR).

7. The method for bonding biological tissue according to claim 1 wherein the first ligand is an RGD linker.

8. The method for bonding biological tissue according to claim 1 wherein the second ligand is an RGD linker.

9. The method for bonding biological tissue according to claim 1 wherein the second ligand is selected from the group consisting of antibody, Fab, F(ab') 2 , Fv, single chain antibody (SCA) and single complementary-determining region (CDR).

10. The method for bonding biological tissue according to claim 1 wherein the first ligand and the first biological tissue form a bond which is degradable by hydrolysis or enzymatic action.

11. The method for bonding biological tissue according to claim 1 wherein the first ligand binds to a receptor selected from the group consisting of peptides, oligosaccharides, oligonucleotides and lipids.

12. The method for bonding biological tissue according to claim 1 wherein the second ligand and the second biological tissue form a bond which is degradable by hydrolysis or enzymatic action.

13. The method for bonding biological tissue according to claim 1 wherein the second ligand binds to a receptor selected from the group consisting of peptides, oligosaccharides, oligonucleotides and lipids.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 9, 2010
From: LADET, SEBASTIEN
To: SOFRADIM PRODUCTION
Reel/Frame 024210/0575 →
Continuity (2)
Provisional Application 61154378 · Feb 21, 2009
Related Publication 20100215659A1 · Aug 26, 2010